Showing results (841-850 of 938) with videos related to
Sort By:
Pageof 94
European Journal of Cancer (Oxford, England : 1990)|April 22, 1999
The objective measurement of remission and progression in metastatic breast cancer by use of serum tumour markers. European Group for Serum Tumour Markers in Breast CancerJ F Robertson, W Jaeger, J J Syzmendera, et al.BMC Public Health|February 17, 2022
A prospective cohort study examining exposure to incarceration and cardiovascular disease (Justice-Involved Individuals Cardiovascular Disease Epidemiology - JUSTICE study): a protocol paperBenjamin A Howell, Lisa B Puglisi, Jenerius Aminawung, et al.Journal of Medicinal Chemistry|July 16, 2016
Design and Characterization of Superpotent Bivalent Ligands Targeting Oxytocin Receptor Dimers via a Channel-Like StructureMarta Busnelli, Gunnar Kleinau, Markus Muttenthaler, et al.Diabetes Care|June 21, 2023
Influence of Gestational Diabetes Mellitus on Diabetes Risk and Glycemic Control in a Retrospective Population-Based CohortKatharine J McCarthy, Shelley H Liu, Mary Huynh, et al.Lancet (London, England)|April 16, 1983
Controlled trial of adjuvant chemotherapy with melphalan for breast cancerR D Rubens, J L Hayward, R K Knight, et al.Clinical Pharmacology and Therapeutics|January 16, 2026
Quantitative Systems Toxicology Modeling with DILIsym to Support Phase 3 Dose Selection for FezolinetantJace C Nielsen, Jeffrey L Woodhead, Brett A Howell, et al.British Journal of Cancer|July 22, 2004
Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancerA J Clayton, S Danson, S Jolly, et al.Clinical Pharmacology and Therapeutics|April 19, 2017
Refining Liver Safety Risk Assessment: Application of Mechanistic Modeling and Serum Biomarkers to Cimaglermin Alfa (GGF2) Clinical TrialsD M Longo, G T Generaux, B A Howell, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2005
High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trialR C Coombes, A Howell, M Emson, et al.Pharmacogenomics|April 1, 2015
Implementation and evaluation of a CYP2C19 genotype-guided antiplatelet therapy algorithm in high-risk coronary artery disease patientsJohn Andrew Lee, Craig R Lee, Brent N Reed, et al.Pageof 94